Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, 110016, China.
Cell Mol Life Sci. 2023 May 20;80(6):160. doi: 10.1007/s00018-023-04792-x.
We previously reported that permanent ischemia induces marked dysfunction of the autophagy-lysosomal pathway (ALP) in rats, which is possibly mediated by the transcription factor EB (TFEB). However, it is still unclear whether signal transducer and activator of transcription 3 (STAT3) is responsible for the TFEB-mediated dysfunction of ALP in ischemic stroke. In the present study, we used AAV-mediated genetic knockdown and pharmacological blockade of p-STAT3 to investigate the role of p-STAT3 in regulating TFEB-mediated ALP dysfunction in rats subjected to permanent middle cerebral occlusion (pMCAO). The results showed that the level of p-STAT3 (Tyr705) in the rat cortex increased at 24 h after pMCAO and subsequently led to lysosomal membrane permeabilization (LMP) and ALP dysfunction. These effects can be alleviated by inhibitors of p-STAT3 (Tyr705) or by STAT3 knockdown. Additionally, STAT3 knockdown significantly increased the nuclear translocation of TFEB and the transcription of TFEB-targeted genes. Notably, TFEB knockdown markedly reversed STAT3 knockdown-mediated improvement in ALP function after pMCAO. This is the first study to show that the contribution of p-STAT3 (Tyr705) to ALP dysfunction may be partly associated with its inhibitory effect on TFEB transcriptional activity, which further leads to ischemic injury in rats.
我们之前曾报道过,永久性缺血会导致大鼠的自噬溶酶体途径(ALP)明显功能障碍,这可能是由转录因子 EB(TFEB)介导的。然而,信号转导和转录激活因子 3(STAT3)是否负责缺血性中风中 TFEB 介导的 ALP 功能障碍仍不清楚。在本研究中,我们使用 AAV 介导的基因敲低和 p-STAT3 的药理学阻断来研究 p-STAT3 在调节大鼠永久性大脑中动脉闭塞(pMCAO)后 TFEB 介导的 ALP 功能障碍中的作用。结果表明,pMCAO 后 24 小时大鼠皮质中 p-STAT3(Tyr705)的水平增加,随后导致溶酶体膜通透性(LMP)和 ALP 功能障碍。这些效应可以通过 p-STAT3(Tyr705)抑制剂或 STAT3 敲低来缓解。此外,STAT3 敲低显著增加了 TFEB 的核转位和 TFEB 靶向基因的转录。值得注意的是,TFEB 敲低显著逆转了 pMCAO 后 STAT3 敲低介导的 ALP 功能改善。这是第一项表明 p-STAT3(Tyr705)对 ALP 功能障碍的贡献可能部分与其对 TFEB 转录活性的抑制作用有关的研究,这进一步导致了大鼠的缺血性损伤。